公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2018 | Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: Week 52 results from SPIRIT-P2 | Genovese M.C.; Combe B.; Kremer J.M.; TSEN-FANG TSAI ; Behrens F.; Adams D.H.; Lee C.; Kerr L.; Nash P. | Rheumatology (United Kingdom) | 35 | 33 |